
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Genital herpes (caused by herpes simplex virus type 1 and, more commonly, type 2) is one of the most common sexually transmitted diseases in the world. It is found in one in five Americans and in more than 80% of people with HIV, where the two viruses significantly affect each other. People with HSV-2 are two to three times more likely to pick up HIV. When HSV-2 erupts, HIV viral loads can rise and genital ulcers are teeming with HIV and T cells. Suppression of HSV-2 reduces the amount of HIV in blood and genital secretions. Now, two studies have looked at the effects of HSV suppression on HIV transmission. The first study involved about 3,200 volunteers infected with HSV-2 from the United States, South America, and Africa and included heterosexual women and men who have sex with men. Participants got either 400 milligrams of acyclovir twice a day or placebo. Everyone received extensive safer-sex counseling and condoms. But at the end of the study 3.9% on acyclovir had picked up HIV compared to 3.3% on placebo, even though the group on acyclovir had a 35% reduction in genital ulcers. The second study involved 3,400 African couples in which one partner had both HIV and HSV-2 and the other had neither. Half of the partners infected with both viruses received 400 milligrams of acyclovir twice a day, and half received placebo. Again, there was no difference in HIV transmission: 41 infections in the acyclovir arm and 43 infections in the placebo arm. Genital ulcers decreased 73% and the HIV viral load decreased by 40% in the acyclovir group. Interestingly, the rate of HIV disease progression slowed by 17% in the treated group. A possible explanation for these results can be found in a paper published in Nature Medicine in August. In this study multiple biopsies were taken from HVS-2-positive/HIV-negative women and men at various time points and locations including active genital ulcers, healed ulcer sites at various intervals over 20 weeks, and normal genital skin that had never had herpes eruptions. They made four interesting discoveries: (1) CD4 cells were found at healed ulcer sites in concentrations two to 37 times greater than unaffected skin, and treatment with acyclovir did not reduce these high concentrations. (2) CD4 cells in the ulcer sites were twice as likely to have the CCR5 attachment molecule that HIV uses, compared to normal skin. (3) Ulcer sites had significantly higher numbers of dendritic cells of the type that transport HIV to the T cells. (4) HIV replicates three to five times faster in tissue from the ulcer sites compared to normal skin. In a nutshell, these studies show that what we really need is a herpes vaccine. But in the meantime, we still need to treat HSV-2 to reduce its transmission and to take its pressure off HIV replication. Bowers is an HIV specialist and is board-certified in family medicine. He is in private practice in New York City. Learn more about Bowers at https://www.danbowersmd.com
DON'T MISS THE OUT100 SPECIAL 3 DAY MARATHON STARTING NOVEMBER 24TH!
Journey through the year’s influential Out100 – the most iconic and long-standing celebration of LGBTQ+ icons and allies – in a 1-hour television special spotlighting the LGBTQ+ people shaping the world today.
WATCH & LIVESTREAM ON ADVOCATECHANNEL.COM
AND ON THE ADVOCATE CHANNEL APP
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Plus: Featured Video
Latest Stories
7 Uplifting Films To Celebrate Trans Awareness Week & Where To Stream Them
November 17 2023 10:25 AM
Out's Deal Guide: Grab Your 50% Off Amazon Fire Tablets & More Recommended Deals on Amazon Today!
November 03 2023 3:44 PM
Unlock Massive Savings at 'The Holiday Shop': Amazon's Hottest Deals of the Season Await!
November 02 2023 2:17 PM
Dianne Feinstein’s Commitment to People Living With HIV Won’t Be Forgotten
November 02 2023 1:27 PM
PEPFAR in Peril: The Far-Right Wants to End the Lifesaving Global HIV Program
October 24 2023 1:52 PM
Plus Nov/Dec Issue: PEPFAR in Danger & Our Allies and Advocates of the Year
October 23 2023 11:53 AM
Trending stories
Most Recent
Recommended Stories for You
Plus Editors
Editor
Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.
Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.